Understand the critical 2026 tax implications for MedTech companies operating in the United States. This post offers an in-depth analysis of upcoming changes and provides actionable strategies for financial planning and compliance.

The US digital health sector is experiencing unprecedented venture capital interest, with over $10 billion in funding shaping its future. This article delves into the driving forces, key investment areas, and projected landscape of digital health by 2026.

Navigating the financial landscape for US MedTech companies in 2026 requires a deep understanding of debt versus equity financing. This guide provides a comprehensive comparison to help drive strategic growth and innovation.

Uncover the multifaceted economic impact of AI on US healthcare spending by 2026. This article analyzes potential cost reductions, investment needs, and the transformative power of AI in diagnosis, treatment, and operational efficiency.

Discover how to secure significant government grants for your US MedTech innovations in 2026. This guide provides essential insights, strategies, and resources to help you fund your next big breakthrough.

The 2026 Cures Act is set to revolutionize MedTech, driving an estimated 8% valuation boost. This article explores the regulatory landscape, key provisions, and strategic opportunities for MedTech companies to capitalize on these changes.

This article delves into the critical strategies for US MedTech companies valued over $5M to attract venture capital in 2026, covering funding rounds, investor insights, and market dynamics.

An in-depth analysis of the 2026 MedTech IPO market, focusing on key financial indicators essential for successful public offerings in the US. Prepare for future investment opportunities.

This article delves into the exciting future of MedTech investments, particularly highlighting the anticipated 15% growth in US digital health startups by 2026. We cover emerging trends, investment strategies, and the regulatory landscape.

This article provides a detailed 3-month financial outlook for US investors in the MedTech market. We analyze key trends, growth drivers, regulatory impacts, and emerging technologies shaping the future of medical technology investment.